Study explores potential long-acting HIV, Hepatitits-B treatment
News Staff
Wednesday, September 22, 2021
Researchers at the University of Nebraska Medical Center (UNMC) have published data in a top scientific journal that may lead to a novel, long-acting treatment for both HIV and Hepatitis B (HBV). The article, “Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles,” is published today in Nature Communications.